Related Experiment Video
Updated: Jun 28, 2026

Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
PARP-1 is involved in autophagy induced by DNA damage
José Antonio Muñoz-Gámez1, José Manuel Rodríguez-Vargas, Rosa Quiles-Pérez
1Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd) and Laboratory of Medical Research, Academical Hospital San Cecilio, Granada, Spain.
Abstract:
Autophagy is a lysosome-dependent degradative pathway frequently activated in tumor cells treated with chemotherapy or radiation. PARP-1 has been implicated in different pathways leading to cell death and its inhibition potentiates chemotherapy-induced cell death. Whether PARP-1 participates in the cell's decision to commit to autophagy following DNA damage is still not known. To address this issue PARP-1 wild-type and deficient cells have been treated with a dose of doxorubicin that induces autophagy. Electron microscopy examination and GFP-LC3 transfection revealed autophagic vesicles and increased expression of genes involved in autophagy (bnip-3, cathepsin b and l and beclin-1) in wild-type cells treated with doxo but not in parp-1(-/-) cells or cells treated with a PARP inhibitor. Mechanistically the lack of autophagic features in PARP-1 deficient/PARP inhibited cells is attributed to prevention of ATP and NAD(+) depletion and to the activation of the key autophagy regulator mTOR. Pharmacological or genetical inhibition of autophagy results in increased cell death, suggesting a protective role of autophagy induced by doxorubicin. These results suggest that autophagy might be cytoprotective during the response to DNA damage and suggest that PARP-1 activation is involved in the cell's decision to undergo autophagy.
Insights
Poly(ADP-ribose) polymerase-1 (PARP-1) activation is crucial for initiating autophagy, a protective cellular process, in response to DNA damage from chemotherapy. PARP-1 deficiency prevents this protective autophagy, leading to increased cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Autophagy is a cellular degradation process often activated in cancer cells during chemotherapy or radiation treatment.
- Poly(ADP-ribose) polymerase-1 (PARP-1) inhibition enhances chemotherapy-induced cell death, but its role in DNA damage-induced autophagy remains unclear.
Purpose of the Study:
- To investigate the role of PARP-1 in the cellular decision to undergo autophagy following DNA damage.
- To determine if PARP-1 activation is necessary for doxorubicin-induced autophagy.
Main Methods:
- Treatment of PARP-1 wild-type and deficient cells with doxorubicin.
- Analysis of autophagic vesicles via electron microscopy and GFP-LC3 transfection.
- Gene expression analysis of autophagy-related genes (bnip-3, cathepsin b and l, beclin-1).
- Assessment of ATP/NAD+ levels and mTOR activation.
Main Results:
- Doxorubicin treatment induced autophagic vesicles and increased autophagy gene expression in wild-type cells, but not in PARP-1 deficient cells or cells treated with a PARP inhibitor.
- Lack of autophagy in PARP-1 deficient/inhibited cells was linked to prevention of ATP/NAD+ depletion and mTOR activation.
- Inhibition of doxorubicin-induced autophagy led to increased cell death, indicating a protective role for autophagy.
Conclusions:
- PARP-1 activation is involved in the cellular decision to initiate autophagy in response to DNA damage.
- Doxorubicin-induced autophagy appears to be a cytoprotective mechanism against DNA damage.
- Targeting PARP-1 may influence the efficacy of chemotherapy by modulating autophagy.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Cellular Injury V: Apoptosis and Autophagy
Long-patch Base Excision Repair
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

